AN UPDATE OF CLINICAL TRIALS LANDSCAPE IN TÜRKİYE

Objective: Clinical research is essential to enhance scientific knowledge and provide better patient outcomes. This work evaluated clinical trials in Türkiye between 2019-2023 and compared them with previous research.Material and Method: Clinical trials in Türkiye registered in the ClinicalTrials.go...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayşegül Özsoy, Selçuk Şen
Format: Article
Language:English
Published: Istanbul University Press 2024-06-01
Series:Sabiad
Subjects:
Online Access:https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/FB006411DB9C47118902BE8080407713
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850194013614768128
author Ayşegül Özsoy
Selçuk Şen
author_facet Ayşegül Özsoy
Selçuk Şen
author_sort Ayşegül Özsoy
collection DOAJ
description Objective: Clinical research is essential to enhance scientific knowledge and provide better patient outcomes. This work evaluated clinical trials in Türkiye between 2019-2023 and compared them with previous research.Material and Method: Clinical trials in Türkiye registered in the ClinicalTrials.gov database between 01.01.2019 and 30.09.2023 were examined and evaluated. Trials were filtered by study type, study phase, recruitment status, funder type, location, condition, or disease. Comparative analyses were executed for different cities and countries.Results: The total number of registered clinical trials in Türkiye was 12,563. The number of trials registered between 2019 and 2023 was 8,851. Of these, 68.21% were interventional and 9.3% were industrysponsored. The majority of trials (61.13%) were completed, while 18.78% were still recruiting patients. Leading cities in Türkiye were Istanbul and Ankara with the highest trial numbers. Despite a remarkable increase in the total number of clinical trials in Türkiye, no considerable change was detected in the number of industry-sponsored trials. The majority of trials with unknown status (85%) were non-industry-sponsored in all countries in the comparative analysis. The highest numbers of trials were found in respiratory, pain/pain management and oncology in Türkiye among the evaluated fields including cardiovascular disease, genetic disorders, diabetes, and obesity.Conclusion: The total number of clinical trials in Türkiye showed a considerable increase when compared with developed countries including Germany, France, and the United Kingdom, however, the reasons behind the lower number and stability in the yearly increase rate of industrysponsored trials should be revisited by all stakeholders.
format Article
id doaj-art-8765bfab0c86486598b697cb76af01a4
institution OA Journals
issn 2651-4060
language English
publishDate 2024-06-01
publisher Istanbul University Press
record_format Article
series Sabiad
spelling doaj-art-8765bfab0c86486598b697cb76af01a42025-08-20T02:14:06ZengIstanbul University PressSabiad2651-40602024-06-01729910610.26650/JARHS2024-1380108123456AN UPDATE OF CLINICAL TRIALS LANDSCAPE IN TÜRKİYEAyşegül Özsoy0https://orcid.org/0009-0008-0709-7710Selçuk Şen1https://orcid.org/0000-0001-7878-793Xİstanbul Üniversitesi, İstanbul, Türkiyeİstanbul Üniversitesi, İstanbul, TürkiyeObjective: Clinical research is essential to enhance scientific knowledge and provide better patient outcomes. This work evaluated clinical trials in Türkiye between 2019-2023 and compared them with previous research.Material and Method: Clinical trials in Türkiye registered in the ClinicalTrials.gov database between 01.01.2019 and 30.09.2023 were examined and evaluated. Trials were filtered by study type, study phase, recruitment status, funder type, location, condition, or disease. Comparative analyses were executed for different cities and countries.Results: The total number of registered clinical trials in Türkiye was 12,563. The number of trials registered between 2019 and 2023 was 8,851. Of these, 68.21% were interventional and 9.3% were industrysponsored. The majority of trials (61.13%) were completed, while 18.78% were still recruiting patients. Leading cities in Türkiye were Istanbul and Ankara with the highest trial numbers. Despite a remarkable increase in the total number of clinical trials in Türkiye, no considerable change was detected in the number of industry-sponsored trials. The majority of trials with unknown status (85%) were non-industry-sponsored in all countries in the comparative analysis. The highest numbers of trials were found in respiratory, pain/pain management and oncology in Türkiye among the evaluated fields including cardiovascular disease, genetic disorders, diabetes, and obesity.Conclusion: The total number of clinical trials in Türkiye showed a considerable increase when compared with developed countries including Germany, France, and the United Kingdom, however, the reasons behind the lower number and stability in the yearly increase rate of industrysponsored trials should be revisited by all stakeholders.https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/FB006411DB9C47118902BE8080407713clinical trialstürkiyeresearch
spellingShingle Ayşegül Özsoy
Selçuk Şen
AN UPDATE OF CLINICAL TRIALS LANDSCAPE IN TÜRKİYE
Sabiad
clinical trials
türkiye
research
title AN UPDATE OF CLINICAL TRIALS LANDSCAPE IN TÜRKİYE
title_full AN UPDATE OF CLINICAL TRIALS LANDSCAPE IN TÜRKİYE
title_fullStr AN UPDATE OF CLINICAL TRIALS LANDSCAPE IN TÜRKİYE
title_full_unstemmed AN UPDATE OF CLINICAL TRIALS LANDSCAPE IN TÜRKİYE
title_short AN UPDATE OF CLINICAL TRIALS LANDSCAPE IN TÜRKİYE
title_sort update of clinical trials landscape in turkiye
topic clinical trials
türkiye
research
url https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/FB006411DB9C47118902BE8080407713
work_keys_str_mv AT aysegulozsoy anupdateofclinicaltrialslandscapeinturkiye
AT selcuksen anupdateofclinicaltrialslandscapeinturkiye
AT aysegulozsoy updateofclinicaltrialslandscapeinturkiye
AT selcuksen updateofclinicaltrialslandscapeinturkiye